Form 4: Abbott Laboratories Director Acquires Stock Equivalent Units

Patricia Paola Gonzalez, a director at Abbott Laboratories, acquired 248 stock equivalent units on March 31, 2025, as part of director fees credited to a grantor trust.

Summary

• On March 31, 2025, Patricia Paola Gonzalez, a director of Abbott Laboratories, acquired 248 stock equivalent units.
• These units were credited to a stock equivalent unit account under a grantor trust.
• The director fees are generally paid in cash at age 65 or upon retirement from the board.
• The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
• The price of the Abbott shares at the time of acquisition was $132.65.
• Following the transaction, Gonzalez directly owns 4,393 stock equivalent units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects a director's continued investment in the company, suggesting confidence in its future.

Positives

• The director's acquisition of stock equivalent units demonstrates confidence in Abbott Laboratories' future performance.

Future Outlook

The stock equivalent units will be paid in cash generally at age 65 or upon retirement from the board, and they earn the same return as if the fees were invested in Abbott shares.

Industry Context

This filing is a routine disclosure of a director's acquisition of stock equivalent units, which is a common practice for compensating board members.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a member of the board of directors.

Key Dates

Keywords

Abbott Laboratories, Director, Stock Equivalent Units, Grantor Trust, Director Fees, ABT